Adamis Pharmaceuticals Corp - FORM 10-K - EX-32.2 - CERTIFICATION BY CFO - March 30, 2017

Attached files

file filename
EX-10.64 - SEPTEMBER 2016 AMENDMENT TO COMMERCIAL LINE OF CREDIT AGREEMENT AND NOTE - Adamis Pharmaceuticals Corpex10-64.htm
EX-32.1 - CERTIFICATION BY CEO - Adamis Pharmaceuticals Corpex32-1.htm
EX-31.2 - CERTIFICATION BY CFO - Adamis Pharmaceuticals Corpex31-2.htm
EX-31.1 - CERTIFICATION BY CEO - Adamis Pharmaceuticals Corpex31-1.htm
EX-23.2 - CONSENT OF HUDSON CISNE & CO., LLP - Adamis Pharmaceuticals Corpex23-2.htm
EX-23.1 - CONSENT OF MAYER HOFFMAN MCCANN P.C. - Adamis Pharmaceuticals Corpex23-1.htm
EX-21.1 - SUBSIDIARIES - Adamis Pharmaceuticals Corpex21-1.htm
EX-10.85 - MARCH 2017 AMENDMENT TO LOAN AND SECURITY AGREEMENT - Adamis Pharmaceuticals Corpex10-85.htm
EX-10.84 - MARCH 2017 AMENDED AND RESTATED LINE OF CREDIT PROMISSORY NOTE - Adamis Pharmaceuticals Corpex10-84.htm
EX-10.83 - EXECUTIVE EMPLOYMENT AGREEMENT - Adamis Pharmaceuticals Corpex10-83.htm
EX-10.81 - EXECUTIVE EMPLOYMENT AGREEMENT - Adamis Pharmaceuticals Corpex10-81.htm
EX-10.80 - BONUS PLAN - Adamis Pharmaceuticals Corpex10-80.htm
EX-10.65 - LOAN RELEASE AGREEMENT DATED AS OF NOVEMBER 14, 2016 - Adamis Pharmaceuticals Corpex10-65.htm
EX-10.63 - AMENDMENT TO LOAN AGREEMENT - Adamis Pharmaceuticals Corpex10-63.htm
EX-10.62 - SEPTEMBER 2016 LOAN AMENDMENT AND CONSOLIDATION AGREEMENT AMONG BEAR STATE BANK, - Adamis Pharmaceuticals Corpex10-62.htm
EX-10.61 - LOAN AMENDMENT AND ASSUMPTION AGREEMENT DATED AS OF NOVEMBER 3, 2016 - Adamis Pharmaceuticals Corpex10-61.htm
EX-10.4 - RESTRICTED STOCK UNIT AWARD GRANT NOTICE AND AWARD AGREEMENT - Adamis Pharmaceuticals Corpex10-4.htm
10-K - ANNUAL REPORT - Adamis Pharmaceuticals Corpadmp_10k-123116.htm
 

ADAMIS PHARMACEUTICALS CORPORATION 10-K

 

 

Exhibit 32.2

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

 

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT

 

The undersigned, Robert O. Hopkins, as Vice President, Finance and Chief Financial Officer of Adamis Pharmaceuticals, Corporation (the “Company”), pursuant to 18 U.S.C.  1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, hereby certifies that, to the best of my knowledge:

 

   (1) the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and
   
   (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

   
  /s/ ROBERT O. HOPKINS
  Robert O. Hopkins
  Vice President and Chief Financial Officer

 

Dated: March 30, 2017 

 

This certification is being furnished to the SEC with this Report on Form 10-K pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934.

 

 

 

 

Stock widget

Investing forum

Adamis Pharmaceuticals Corp Reports